Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
246
Frequently Asked Questions
What is Market Cap of Editas Medicine Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Editas Medicine Inc market cap is $291.34M.
What is the 52-week high for Editas Medicine Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Editas Medicine Inc 52 week high is $3.80 as of September 27, 2025.
What is the 52-week low for Editas Medicine Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Editas Medicine Inc 52 week low is $0.9101 as of September 27, 2025.
What is Editas Medicine Inc stock price today?
Editas Medicine Inc stock price today is $3.24.
What was Editas Medicine Inc stock price yesterday?
Editas Medicine Inc stock price yesterday was $3.23.
What is the PE ratio of Editas Medicine Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Editas Medicine Inc’s P/E ratio is -1.14.
What is the Price-to-Book ratio of Editas Medicine Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Editas Medicine Inc P/B ratio is 14.7554.
What is the 50-day moving average of Editas Medicine Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Editas Medicine Inc 50-day moving average is $2.77.